mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.4 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.4 |